Skip to main content

Timely Follow-Up After Acute Exacerbations of Chronic Conditions

CBE ID
3455
Endorsed
New or Maintenance
Is Under Review
No
Measure Description

The percentage of issuer-product-level acute events requiring either an emergency department (ED) visit or hospitalization for one of the following 6 chronic conditions: hypertension, asthma, heart failure (HF), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), or diabetes mellitus (Type I or Type II), where follow-up was received within the timeframe recommended by clinical practice guidelines in a non-emergency outpatient setting.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    MAT output not attached
    Attached
    Numerator

    The numerator is the sum of the issuer-product-level denominator events (Emergency Room [ED], observation hospital stay or inpatient hospital stay) for acute exacerbation of hypertension, asthma, heart failure (HF), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), or diabetes where follow-up was received within the timeframe recommended by clinical practice guidelines, as detailed below:

    • Hypertension: Within 7 days of the date of discharge
    • Asthma: Within 14 days of the date of discharge
    • HF: Within 14 days of the date of discharge
    • CAD: Within 14 days of the date of discharge
    • COPD: Within 30 days of the date of discharge
    • Diabetes: Within 30 days of the date of discharge

    Denominator

    The denominator is the sum of the plan-product-level acute exacerbations that require either an ED visit, observation stay, or inpatient stay (i.e., acute events) for any of the six conditions listed above (hypertension, asthma, HF, CAD, COPD, or diabetes).

    Exclusions

    The measure excludes events with:

    1. Subsequent acute events that occur two days after the prior discharge, but still during the follow-up interval of the prior event for the same reason. To prevent double-counting, only the first acute event will be included in the denominator.
    2. Acute events after which the patient does not have continuous enrollment for 30 days in the same product.
    3. Acute events where the discharge status of the last claim is not “to community” (“Left against medical advice” is not a discharge to community.)
    4. Acute events for which the calendar year ends before the follow-up window ends (e.g., acute asthma events ending fewer than 14 days before December 31)
    5. Acute events where the patient enters a skilled nursing facility (SNF), non-acute care, or hospice care within the follow-up interval

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
    Testing Data Sources
  • Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Endorsed Patient Experience and Function Fall Cycle 2018
    Initial Endorsement
    Next Planned Maintenance Review
    Spring 2024
    Endorsement Status
    Last Updated
  • Do you have a secondary measure developer point of contact?
    On
    Measure Developer Secondary Point Of Contact

    Rachel Johnson-DeRycke
    United States

    Measure Developer Secondary Point Of Contact Phone Number
    The measure developer is NOT the same as measure steward
    On
    Steward Organization Email
    Steward Phone Number
    Steward Address

    Teresa Winder-Wells
    United States

    Steward Organization Copyright

    Not applicable

  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off
    If no, attest that all information will be provided in other fields in the submission.
    Off